Any substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals.
| Member | Definition | Class |
|---|
| 1,6-hexamethylene diisocyanate | A diisocyanate compound with the two isocyanates linked by a hexane-1,6-diyl group. | hexamethylene diisocyanate |
| 2,2-dichloroacetyl chloride | The acyl chloride obtained by displacement of the hydroxy group of dichloroacetic acid by chloride. | dichloroacetyl chloride |
| 2,4-dinitrothiocyanatobenzene | A thiocyanate compound having a 2,4-dinitrophenyl group attached to the sulfur atom. | 2,4-dinitro-1-thiocyanatobenzene |
| 2,6-diisocyanatotoluene | A toluene meta-diisocyanate in which the isocyanato groups are at positions 2 and 6 relative to the methyl group on the benzene ring. | toluene 2,6-diisocyanate |
| 3,5-dinitrosalicylic acid | A monohydroxybenzoic acid consisting of 2-hydroxybenzoic acid having nitro substituents at the 3- and 5-positions. It is used in colorimetric testing for the presence of free carbonyl groups (C=O) in reducing sugars. | 3,5-dinitrosalicylic acid |
| 4-(2-thienyl)butyric acid | A monocarboxylic acid that is butyric acid bearing a 2-thienyl group at position 4. | 4-(2-thienyl)butyric acid |
| 4-hydroxy-3-nitrophenylacetyl-o-succinimide ester | The ester formed between N-hydroxysuccinimide and (4-hydroxy-3-nitrophenyl)acetic acid. | 1-((4-hydroxy-3-nitrophenyl)acetoxy)pyrrolidine-2,5-dione |
| 4-methylcatechol | A methylcatechol having a single methyl substituent at the 4-position. It has been isolated from Picea abies. | 4-methylcatechol |
| 4-nitrophenylphosphorylcholine | A phosphocholine that is the 4-nitrophenyl ester of choline phosphate. | p-nitrophenylphosphocholine |
| 4-phenylenediamine | A phenylenediamine in which the amino functions are at positions 1 and 4 of the benzene nucleus. | 1,4-phenylenediamine |
| 4-tolyl isocyanate | An isocyanate comprising a benzene core with isocyanato and methyl substituents para to each other. | 4-tolyl isocyanate |
| 4,4'-diphenylmethane diisocyanate | A diisocyanate consisting of diphenylmethane with two isocyanate groups at the 4- and 4'-positions. | diphenylmethane-4,4'-diisocyanate |
| benzenediazonium | The aromatic diazonium ion formed from diazotisation of aniline. | benzenediazonium |
| benzoylpropionic acid | A 4-oxo monocarboxylic acid that is butyric acid bearing oxo and phenyl substituents at position 4. | 4-oxo-4-phenylbutyric acid |
| butyl isothiocyanate | An isothiocyanate having a butyl group attached to the nitrogen. | butyl isothiocyanate |
| digoxigenin | A hydroxy steroid that consists of 5beta-cardanolide having a double bond at the 20(22)-position as well as hydroxy groups at the 3beta-, 12beta- and 14beta-positions. It has been isolated from the plant species of the genus Digitalis. | digoxigenin |
| diphenylcyclopropenone | A cyclopropenone compound having phenyl substituents at the 2- and 3-positions. | diphenylcyclopropenone |
| disperse blue 124 | A monoazo compound consisting of diazene with a 5-nitrothiazol-2-yl group attached to one nitrogen and a substituted 4-aminophenyl group attached to the other; used as a dye standard for the assay of allergy-releasing dyes in textiles. | Disperse Blue 124 |
| domoic acid | An L-proline derivative that is L-proline substituted by a carboxymethyl group at position 3 and a 6-carboxyhepta-2,4-dien-2-yl group at position 4. It is produced by the diatomic algal Pseudo-nitzschia. It is an analogue of kainic acid and a neurotoxin which causes amnesic shellfish poisoning (ASP). | domoic acid |
| levodopa | An optically active form of dopa having L-configuration. Used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease | L-dopa zwitterion; L-dopa |
| mannitol | The D-enantiomer of mannitol. | D-mannitol |
| methyldopa | A derivative of L-tyrosine having a methyl group at the alpha-position and an additional hydroxy group at the 3-position on the phenyl ring. | alpha-methyl-L-dopa |
| nickel chloride | A compound of nickel and chloride in which the ratio of nickel (in the +2 oxidation state) to chloride is 1:2. | nickel dichloride |
| phenyl isocyanate | An isocyanate composed of a benzene ring bearing a single isocyanato substituent. | phenyl isocyanate |
| phenylethyl isocyanate | An isocyanate having a 2-phenylethyl group attached to the nitrogen. | 2-phenylethyl isocyanate |
| phosphorylcholine | The phosphate of choline; and the parent compound of the phosphocholine family. | phosphocholine |
| picryl chloride | The C-nitro compound that is chlorobenzene with three nitro substituents in the 2-, 4- and 6-positions. | 1-chloro-2,4,6-trinitrobenzene |
| primin | A 1,4-benzoquinone having a methoxy substituent at the 2-position and a pentyl substituent at the 6-position. | primin |
| toluene 2,4-diisocyanate | A toluene meta-diisocyanate in which the isocyanato groups are at positions 2 and 4 relative to the methyl group on the benzene ring. | toluene 2,4-diisocyanate |
| trimellitic anhydride | A 2-benzofuran compound having oxo groups at the 1- and 3-positions and a carboxy substituent at the 5-position; the cyclic anhydride formed from the carboxy groups at the 1- and 2-positions of trimellitic acid. | trimellitic anhydride |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 28.7968 | 1 | 2 |
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 20.5348 | 1 | 2 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | Leishmania major strain Friedlin | Potency | 37.9330 | 1 | 1 |
| 67.9K protein | Vaccinia virus | Potency | 1.1220 | 2 | 2 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 46.7379 | 2 | 10 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 20.9739 | 2 | 7 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 15.2645 | 1 | 3 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 17.8431 | 1 | 3 |
| AR protein | Homo sapiens (human) | Potency | 26.2134 | 10 | 37 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 29.4680 | 3 | 16 |
| arylsulfatase A | Homo sapiens (human) | Potency | 37.9330 | 1 | 2 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 3.7295 | 2 | 3 |
| Ataxin-2 | Homo sapiens (human) | Potency | 49.3104 | 2 | 6 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 21.2604 | 4 | 5 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 53.5554 | 2 | 7 |
| atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 23.9341 | 1 | 1 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 6.5592 | 3 | 4 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 15.8489 | 1 | 1 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 30.3988 | 1 | 2 |
| caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 13.3332 | 1 | 1 |
| caspase-3 | Homo sapiens (human) | Potency | 30.3988 | 1 | 2 |
| Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 13.3332 | 1 | 1 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 49.7431 | 2 | 9 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 10.8064 | 1 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 4.9472 | 2 | 4 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 52.5784 | 2 | 3 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 15.8489 | 1 | 1 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 1.4744 | 1 | 3 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 48.8575 | 1 | 4 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 9.5993 | 2 | 6 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 11.7669 | 1 | 6 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 0.5989 | 1 | 3 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 1.4744 | 1 | 3 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 36.3296 | 2 | 5 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 18.6816 | 1 | 2 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 3.0901 | 1 | 1 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 15.0340 | 2 | 8 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 0.5466 | 2 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 49.0375 | 1 | 7 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 23.2809 | 1 | 1 |
| DNA polymerase beta | Homo sapiens (human) | Potency | 1.2673 | 1 | 2 |
| DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 14.1179 | 2 | 3 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 11.1231 | 2 | 5 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 7.1576 | 1 | 8 |
| dopamine D1 receptor | Homo sapiens (human) | Potency | 8.1995 | 1 | 1 |
| endonuclease IV | Escherichia coli | Potency | 31.6228 | 1 | 1 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 37.6529 | 11 | 48 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 13.3037 | 3 | 9 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 25.7282 | 6 | 43 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 17.7556 | 1 | 7 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 0.3722 | 1 | 1 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 33.5882 | 3 | 6 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 28.6496 | 3 | 8 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 15.8489 | 1 | 1 |
| G | Vesicular stomatitis virus | Potency | 18.6816 | 1 | 2 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 15.0340 | 1 | 4 |
| geminin | Homo sapiens (human) | Potency | 9.2586 | 2 | 10 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 28.7826 | 3 | 23 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 0.5012 | 1 | 1 |
| GLS protein | Homo sapiens (human) | Potency | 20.4751 | 2 | 5 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 35.7477 | 5 | 12 |
| glucokinase regulatory protein | Homo sapiens (human) | Potency | 5.0119 | 1 | 1 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 35.7372 | 1 | 5 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 26.1678 | 2 | 5 |
| hexokinase-4 isoform 1 | Homo sapiens (human) | Potency | 5.0119 | 1 | 1 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 11.0344 | 1 | 2 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 47.9717 | 2 | 5 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 51.9127 | 2 | 16 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 18.6816 | 1 | 2 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 14.1254 | 1 | 1 |
| hypothetical protein, conserved | Trypanosoma brucei | Potency | 13.4591 | 1 | 1 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 23.1366 | 2 | 6 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 10.0000 | 2 | 2 |
| IDH1 | Homo sapiens (human) | Potency | 2.0596 | 1 | 1 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 79.7436 | 1 | 3 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 18.6816 | 1 | 4 |
| Interferon beta | Homo sapiens (human) | Potency | 18.6816 | 1 | 2 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 35.4813 | 1 | 2 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 31.6228 | 1 | 1 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 43.3784 | 3 | 11 |
| lysosomal alpha-glucosidase preproprotein | Homo sapiens (human) | Potency | 3.5481 | 1 | 1 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 18.0255 | 1 | 3 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 18.1880 | 2 | 9 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 0.0708 | 1 | 1 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 50.1187 | 1 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 3.9811 | 1 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 16.3562 | 3 | 15 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 0.4611 | 2 | 2 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 38.0723 | 2 | 4 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 60.8524 | 1 | 2 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 23.2709 | 2 | 6 |
| nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 16.1936 | 1 | 2 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 27.1819 | 3 | 26 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 0.7667 | 1 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 49.8910 | 2 | 4 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 7.9198 | 2 | 4 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 84.9214 | 1 | 1 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 35.4514 | 5 | 7 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 30.5683 | 3 | 6 |
| phosphoglycerate kinase | Trypanosoma brucei brucei TREU927 | Potency | 9.6637 | 3 | 4 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 62.7181 | 3 | 6 |
| polyprotein | Zika virus | Potency | 15.8489 | 1 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 57.4570 | 1 | 2 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 38.1152 | 3 | 14 |
| progesterone receptor | Homo sapiens (human) | Potency | 29.4575 | 2 | 8 |
| pyruvate kinase | Leishmania mexicana mexicana | Potency | 10.5241 | 2 | 5 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 21.8400 | 2 | 17 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 2.5119 | 1 | 1 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 26.6795 | 1 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 28.4996 | 3 | 28 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 23.4990 | 2 | 15 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 23.0014 | 4 | 4 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 19.7556 | 2 | 3 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 19.7556 | 2 | 3 |
| Smad3 | Homo sapiens (human) | Potency | 6.9906 | 1 | 2 |
| snurportin-1 | Homo sapiens (human) | Potency | 79.7436 | 1 | 3 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 1.5849 | 1 | 1 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 0.8913 | 1 | 1 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| TDP1 protein | Homo sapiens (human) | Potency | 21.8331 | 2 | 7 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 12.9676 | 1 | 2 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 17.5518 | 2 | 6 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 33.0006 | 3 | 12 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 19.9526 | 1 | 1 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 36.5362 | 6 | 14 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 21.5682 | 2 | 2 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 50.1187 | 1 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 15.1450 | 2 | 5 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 21.5597 | 4 | 8 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 52.2578 | 1 | 4 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 35.7372 | 1 | 5 |
| WRN | Homo sapiens (human) | Potency | 5.4979 | 2 | 2 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | KA | 11.4000 | 1 | 1 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | KA | 11.4000 | 1 | 2 |
| Carbonic anhydrase | Candida albicans SC5314 | KA | 0.9600 | 1 | 1 |
| Carbonic anhydrase | Methanosarcina thermophila | KA | 39.0000 | 1 | 1 |
| Carbonic anhydrase | Methanothermobacter thermautotrophicus str. Delta H | Ka | 11.4000 | 1 | 1 |
| Carbonic anhydrase | Saccharomyces cerevisiae S288C | Ka | 90.0000 | 2 | 2 |
| Carbonic anhydrase | Cryptococcus neoformans var. grubii | KA | 43.3000 | 1 | 1 |
| Carbonic anhydrase | Nakaseomyces glabratus CBS 138 | Ka | 23.3000 | 1 | 1 |
| Carbonic anhydrase 1 | Homo sapiens (human) | KA | 3.1000 | 11 | 11 |
| Carbonic anhydrase 12 | Homo sapiens (human) | KA | 1.6700 | 1 | 1 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | KA | 43.0000 | 1 | 1 |
| Carbonic anhydrase 14 | Homo sapiens (human) | KA | 12.1000 | 1 | 1 |
| Carbonic anhydrase 15 | Mus musculus (house mouse) | KA | 6.5000 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | KA | 11.4000 | 13 | 13 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Ka | 13.5000 | 2 | 2 |
| Carbonic anhydrase 4 | Homo sapiens (human) | KA | 15.3000 | 2 | 2 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | KA | 0.0360 | 1 | 1 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | KA | 0.0630 | 1 | 1 |
| Carbonic anhydrase 6 | Homo sapiens (human) | KA | 18.0000 | 2 | 2 |
| Carbonic anhydrase 7 | Homo sapiens (human) | KA | 58.3000 | 1 | 1 |
| Carbonic anhydrase 9 | Homo sapiens (human) | KA | 51.3000 | 1 | 1 |
| Carbonic anhydrase-like protein, putative | Trypanosoma cruzi strain CL Brener | KA | 0.8300 | 1 | 1 |
| Caspase 6, apoptosis-related cysteine peptidase | Homo sapiens (human) | AC50 | 39.2300 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | KA | 58.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | KA | 58.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | KA | 58.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | KA | 58.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | KA | 58.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | KA | 58.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | KA | 58.3000 | 1 | 1 |
| Monocarboxylate transporter 10 | Rattus norvegicus (Norway rat) | Km | 6,430.0000 | 1 | 1 |
| PAX8 | Homo sapiens (human) | AC50 | 2.3500 | 1 | 1 |
| Peptidylglycine alpha-amidating monooxygenase | Rattus norvegicus (Norway rat) | Kis | 2,900.0000 | 1 | 1 |
| Plasma kallikrein | Homo sapiens (human) | KA | 0.0630 | 1 | 1 |
| Polyphenol oxidase 2 | Agaricus bisporus | Km | 860.0000 | 1 | 1 |
| SLC16A10 protein | Homo sapiens (human) | Km | 1,212.5000 | 1 | 1 |